1 / 47

Intellectual Property and Technology Transfer Issues US Perspective

The National Cancer Institute (NCI) has been fostering collaborations with industry for over two decades, supporting clinical trials from early-phase to phase 3 studies. These partnerships have adapted to incorporate new discoveries and advancements in technology. Amid the complexities of intellectual property and technology transfer, NCI aims to streamline processes, enhance innovation, and facilitate the development of novel therapeutic solutions. This overview highlights the significance of these collaborations in advancing drug development and bringing effective treatments to patients.

kerryn
Download Presentation

Intellectual Property and Technology Transfer Issues US Perspective

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related